Biomarkers in the News


Program News


Radiologists Urge FDA To Accept PET-Based Tumor Response Criteria in Clinical Trials

In May, the U.S. Food and Drug Administration will meet with two groups who have proposed that the agency accept the use of fluorodeoxyglucose – positron emission tomography (FDG – PET) imaging to measure tumor...

 

Biomarkers Consortium Project Aims To Develop Well-Defined Endpoints in Antibacterial Clinical Trials for Bacterial Pneumonia and Skin Infections

Community-Acquired Bacterial Pneumonia (CABP) is a leading cause of morbidity and mortality. It is estimated that approximately one million episodes of CABP occur annually in adults 65 years of age and older in the United States. Overall mortality remains relatively high, ranging from 5.1% for patients hospitalized or treated in an ambulatory setting to 36.5% for patients treated in an intensive care unit (Fine et al., JAMA, 1996) ...

 

The Biomarkers Consortium Launches I-SPY 2 Breast Cancer Clinical Trial

The Biomarkers Consortium The Biomarkers Consortium Launches I-SPY 2 Breast Cancer Clinical Trial … — The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug …


Biomarker Qualification Journal Article

The Biomarkers Consortium Biomarker Qualification Journal Article In December 2009, Foundation for NIH board member and Biomarkers Consortium Executive Committee member Steven Paul co-authored an article with Stephen …


Competitors Try Collaboration To Speed Drug Development

I-SPY 2: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis The Biomarkers Consortium Competitors …


Trial on the Fly

I-SPY 2: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis The Biomarkers Consortium Trial …


BioCentury: Spies Plot Revolution

The Biomarkers Consortium Bio … partnership between the NCI, FDA, pharmaceutical companies, academic cancer centers, and the FNIH Biomarkers Consortium was instrumental in the formation of this unique project. Multiple biomarkers and ant …


CR Magazine: A New Approach to Clinical Trials

I-SPY 2: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis The Biomarkers Consortium CR Magazine …


A New RX for Medicine

I-SPY 2: Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis The Biomarkers Consortium A New RX …